| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |